Stay updated on Nivolumab in ER+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in ER+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The Locations section has been refreshed with numerous new site entries across the U.S. and internationally. The prior location listings have been removed in favor of the updated, expanded site list.
    Difference
    2%
    Check dated 2025-12-23T12:38:01.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The Publications section now clarifies that PubMed publications are automatically populated from PubMed. The revision tag has been updated to Revision: v3.3.2, replacing the prior v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-24T18:47:37.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Two new trial locations were added in Tainan, Taiwan (70457 and 71004), and the entries 'Tainan City, Taiwan, 70457' and 'Tainan City, Taiwan, 71004' were removed.
    Difference
    0.1%
    Check dated 2025-11-17T18:04:09.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The study record’s core details, including title, NCT number, enrollment, and locations, appear unchanged between the two screenshots. Any visible differences are limited to formatting or layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T12:48:30.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Cali, Colombia has been added as a study site and Santiago de Cali, Colombia has been removed. This changes the geographic availability for trial participation.
    Difference
    0.1%
    Check dated 2025-10-27T09:11:25.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    2%
    Check dated 2025-10-05T17:37:46.000Z thumbnail image

Stay in the know with updates to Nivolumab in ER+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.